CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Holdings History for SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS)

Symbol: SLS on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$1,539,672	408,401	+114,295	+39%	$3.77	Q4 2025
30 Sep 2025	0%	0%	$473,511	294,106	0		$1.61	Q3 2025
30 Jun 2025	0%	+0%	$644,092	294,106	+277,868	+1711%	$2.19	Q2 2025
31 Mar 2025	0%	0%	$17,537	16,238	0		$1.08	Q1 2025
31 Dec 2024	0%	0%	$16,888	16,238	0		$1.04	Q4 2024
30 Sep 2024	0%	0%	$20,298	16,238	0		$1.25	Q3 2024
30 Jun 2024	0%	0%	$19,323	16,238	0		$1.19	Q2 2024
31 Mar 2024	0%	0%	$16,400	16,238	0		$1.01	Q1 2024
31 Dec 2023	0%	0%	$17,212	16,238	0		$1.06	Q4 2023
30 Sep 2023	0%	0%	$26,630	16,238	0		$1.64	Q3 2023
30 Jun 2023	0%	0%	$25,494	16,238	0		$1.57	Q2 2023
31 Mar 2023	0%	0%	$23,220	16,238	0		$1.43	Q1 2023
31 Dec 2022	0%	0%	$38,322	16,238	0		$2.36	Q4 2022
30 Sep 2022	0%	+0%	$33,000	16,238	+16,238	NEW	$2.03	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.